Image
14.12.2023
Harry Irvine celebrates 20 years of fundraising with one last communit...
Local Parkgate man Harry Irvine and his family recently completed their last Parkgate Donkey Day and Vint...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more